Bioduro LLC

Form 483 issued February 23, 2024 · Irvine, California

Inspection
Feb 12 – Feb 23, 2024
Investigator
Bryan A. Galvez
Observations
8
Pages
7
FEI number
3004492248

In short: On February 23, 2024, FDA issued a Form 483 with 8 observations to Bioduro LLC in Irvine, California (FEI 3004492248) after an inspection that ran Feb 12 – Feb 23, 2024. The investigator was Bryan A. Galvez. Most observations concern quality system and laboratory controls; the most-cited regulation is 21 CFR 211.165 (testing and release for distribution).

At a glance

Quality system and laboratory controls account for 6 of 8 observations.

Quality system3
Laboratory controls3
Facilities & equipment1
Production1

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review the failure of a batch or any of its…

  2. 02

    Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate…

  3. 03

    Your firm failed to establish written procedures for production and process controls designed to assure that…

  4. 04

    Records are not maintained so that data therein can be reviewed at least annually to evaluate…

4 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Bioduro LLC?

FDA listed 8 observations on this Form 483, mostly about quality system, laboratory controls and facilities & equipment. The most-cited regulation is 21 CFR 211.165 (testing and release for distribution). The opening words of each observation are shown on this page.

Who inspected Bioduro LLC?

Bryan A. Galvez is named on this Form 483, for the inspection of Feb 12 – Feb 23, 2024. Each investigator has a profile showing what they cite most.

When was Bioduro LLC inspected by FDA?

The inspection ran Feb 12 – Feb 23, 2024, and the Form 483 is dated February 23, 2024.

How do I get the full Form 483 for Bioduro LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free